Reanalysis of the Women's Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit

Marcia L Stefanick; Ross L Prentice; Garnet Anderson; Margery Gass; JoAnn E Manson; Susan L Hendrix; Diane Vista-Deck; Gene McNeeley; Women's Health Initiative Steering Committee

doi:10.1016/j.fertnstert.2005.01.084

Reanalysis of the Women's Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit

Fertil Steril. 2005 Apr;83(4):853-4. doi: 10.1016/j.fertnstert.2005.01.084.

Authors

Marcia L Stefanick¹, Ross L Prentice, Garnet Anderson, Margery Gass, JoAnn E Manson, Susan L Hendrix, Diane Vista-Deck, Gene McNeeley; Women's Health Initiative Steering Committee

Affiliation

¹ Stanford Prevention Research Center, Departments of Medicine and of Obstetrics and Gynecology, Hoover Pavilion, Stanford University, 211 Quarry Road, Stanford, CA 94305-5705, USA. stefanick@stanford.edu

PMID: 15820789
DOI: 10.1016/j.fertnstert.2005.01.084

Abstract

Reanalysis of the Women's Health Initiative (WHI) data regarding prior oral contraceptive use and the effect on cardiovascular disease reveals no evidence of a delayed benefit or harm. The WHI database was not designed to answer this question.

Publication types

Review

MeSH terms

Cardiovascular Diseases / prevention & control*
Contraceptives, Oral / therapeutic use*
Databases, Factual*
Female
Humans
Women's Health*

Substances

Contraceptives, Oral